Aclaris Therapeutics (ACRS) Earnings Date & Reports

Industry: @Pharmaceuticals Other

Get AI intraday signals

A.I. Advisor

published Earnings

ACRS is expected to report earnings to rise 35.09% to -14 cents per share on February 20

Aclaris Therapeutics ACRS Stock Earnings Reports

Q4'24

Est.

$-0.15

Q3'24

Missed

by $0.10

Q2'24

Beat

by $0.05

Q1'24

Beat

by $0.05

Q4'23

Beat

by $0.32

The last earnings report on November 06 showed earnings per share of -10 cents, missing the estimate of 0 cents. With 1.16M shares outstanding, the current market capitalization sits at 87.95M.

View a ticker or compare two or three

Compare

ACRS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For ACRS
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a manufacturer of novel dermatological therapies

Industry MedicalSpecialties

Profile

Fundamentals

Details

Industry

Pharmaceuticals Other

Address

701 Lee Road

Phone

+1 484 324-7933

Employees

Web

https://www.aclaristx.com